$ARTH ~ Arch Therapeutics, Inc. is a biotechnology company developing an innovative, elegant, and superior approach to the rapid cessation of bleeding and control of fluid leakage during surgery and trauma care. The underlying technology, exclusively licensed from a leading university, supports an innovative platform of smart materials that fulfill the criteria as a solution for a specialized field we call, “stasis and barrier applications.” For more information visit: http://www.archtherapeutics.com